Clinical Trial Update: TPF+CCRT vs.CCRT+PF in High Risk Nasopharyngeal Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing TPF+CCRT versus CCRT+PF for high-risk nasopharyngeal carcinoma is active but not currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• CCRT+PF
• TPF+CCRT

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING